Good morning.

Vireo Growth’s Sam Armenia joins Cultivated Live today at 10 a.m. ET to break down the company’s third-quarter results and the deal spree reshaping the operator landscape. Vireo has done 17 deals in 22 months and says it’s on a path to a billion-dollar revenue run rate. Nobody else in cannabis is consolidating this fast.

Watch it on YouTube, our LinkedIn, and Jeremy’s X page. See you there!

Let’s get to it.

-JB, JR

Today’s newsletter is 1,109 words or about a 7-minute read.

CULTIVATED CALENDAR

December 2 » Cultivated Subscribers’ Breakfast Las Vegas → Open to all subscribers. Secret Las Vegas location.
December 17 » Cultivated Buffalo powered by Jaunty → Our first event in Western New York. Get tickets today!

Visit our revamped Events Page »

Quotable

“Texas f****d up. They passed some crazy laws banning THC products and it's probably cost them the election,” podcaster and (former) Trump booster Joe Rogan said on his podcast last week. When you’ve lost Joe…

Texas, as you all now know, went Blue and state Republicans’ insistence on banning cannabis was a huge reason why. Still, cannabis legalization didn’t make the top of Senator-elect James Talarico’s priority list on Monday.

Thought bubble

Sports betting vs cannabis?

There’s obviously a lot of resonance between sports betting and cannabis. 

Lawmakers took a large, illicit market with pent up demand, and made a choice to regulate instead of prohibit. Of course, not all regulations are the same, and the modern American legal cannabis and sports-betting industries are reflections of the country’s capitalist economic system itself, with public health in some instances at best a proximate concern. 

This very worthwhile New Yorker story about former NBA player Jontay Porter, his gambling addiction, and what the spread of betting apps and prediction markets means for our society got me thinking about the overlap between DraftKings and cannabis.

Look, I’m not against sports betting or prediction markets on principle. It’s better for these activities to be taxed and regulated than criminalized. The vast majority of adults who use these products can handle themselves. But there’s a small percentage of people who can’t — and how to protect those vulnerable individuals is an open question. 

Still, the comparison breaks with cannabis in a key way, at least to me: There are real benefits to widespread access to cannabis legalization, and research has only scratched the surface on medical and therapeutic potential. That, and the fact that legalization is a real step to ending the sordid history of racist policing in the U.S. and around the world.

I’m not sure there are any real benefits to getting a frictionless Las Vegas on your phone, other than to the shareholders and employees of those companies.

Still, regulation is generally a better way to ameliorate harm and capture benefit than prohibition. It’s more obvious for cannabis. The argument is getting more difficult to make for gambling and what it’s doing to sports and (mostly) young men.

And on that front, the drip-drip-drip of corruption allegations within the Trump Administration when it comes to regulating this stuff, whether that’s hemp-derived THC, nicotine vapes, or prediction markets, is not a good look for any industry. 

The intersection between illicit markets, capitalism, and regulation is always fascinating, whether that’s drugs, gambling, or anything else. 

-JB

Quick hits

Rep. Comer wants hemp fix in must-pass spending bill before Dec. 11 ban

Rep. James Comer (R-Ky.) told Kentucky hemp industry members he’ll push to add hemp protections to a must-pass federal spending bill, since he doesn’t expect a standalone bill to get a vote before the federal ban takes effect December 11. “We’re down to 27 days until my whole business could be illegal,” said Kentucky Hemp Association President Dee Dee Taylor, who owns Louisville’s 502 Hemp.

Illinois starts enforcing 0.4 milligram THC cap on hemp products

The Illinois Department of Financial and Professional Regulation has started visiting suspected unlicensed sellers of products with more than 0.4 milligrams of total THC per container, which became cannabis under state law on November 12 and can now draw fines of up to $10,000 a day. Hemp businesses covered by a federal lawsuit from the Illinois Healthy Alternatives Association can keep selling until at least a November 19 hearing.

Senate appropriators keep medical cannabis protections, skip rescheduling block

The Senate Appropriations Committee posted a fiscal 2027 Commerce, Justice and Science spending bill that renews protections for state medical cannabis programs but leaves out the House’s provision barring funds for rescheduling. A separate Homeland Security report directs Customs and Border Protection to brief Congress within 120 days on seizures of products from state-legal businesses, after criticism from New Mexico Gov. Michelle Lujan Grisham.

Deals, launches, partnerships

UK pharmacy chain Boots launches medical cannabis service

British pharmacy chain Boots launched SureLeaf, a private medical cannabis service for patients 25 and older with conditions like chronic pain, insomnia and generalized anxiety disorder who haven’t found relief from conventional treatments. A one-month trial costs £89, and a second, independent consultant reviews every prescription before treatment starts.

Sweet Flower workers authorize unfair labor practice strike

Sweet Flower dispensary workers represented by UFCW Local 770 voted to authorize an unfair labor practice strike, and the union has filed National Labor Relations Board charges alleging the company stalled bargaining on a contract that expired March 8. The two sides return to the table November 18, a week before Green Wednesday.

Cultivated Live

Ben Stoller, founder of Cannaprint and Cannadots, made his first appearance on Monday’s Cultivated Live.

He covered his path from hedge funds to private equity to cannabis, and how a flat-printing technology built for supplements became one of the fastest-growing products in the market. We also got into budtender relationships, the grind of distribution, and why 28 patents might be the moat that matters.

In case you missed it »

Earnings roundup

Glass House revenue more than doubles to $56.8 million

Glass House Brands reported third-quarter revenue of $56.8 million on a record harvest, but its net loss widened to $10.1 million from $6.7 million last quarter as wholesale prices fell to $151 a pound from $211. The results come days after the company pushed out auditor BDO, which sent shares down more than 33% to about $1.25 last Thursday. $GLAS ( ▲ 1.58% )

Canadian cannabis company Rubicon Organics reported third-quarter net revenue of $18.3 million (CAD), up 17% from a year earlier, while adjusted EBITDA fell 17% to $1.4 million as costs from its new Cascadia facility showed up for the first time. $ROMJ.TSX ( 0.0% ) $ROMJF

What we’re reading

What did you think of today's Cultivated Daily?

Login or Subscribe to participate